MDT Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

76.520

Open

76.250

VWAP

75.15

Vol

10.49M

Mkt Cap

95.70B

Low

74.400

Amount

788.75M

EV/EBITDA(TTM)

11.73

Total Shares

1.28B

EV

117.67B

EV/OCF(TTM)

16.15

P/S(TTM)

--

Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.

Show More

Events Timeline

(ET)

2026-04-30

10:00:00

Orchestra BioMed Receives Second Breakthrough Device Designation from FDA

2026-04-30

07:20:00

Teleflex Appoints Jason Weidman as New CEO

2026-04-26 (ET)

2026-04-26

22:00:00

Sun Pharma to Acquire Organon for $14 Per Share

2026-04-26

13:50:00

Medtronic Announces Continued Growth for Cardiac Technologies

2026-04-26

13:50:00

Medtronic's Sphere-9 Catheter Receives FDA Breakthrough Device Designation

News

CNBC

Market Punishes Stocks More Aggressively, Tech Stocks Favored

Newsfilter

05-11Newsfilter

Market Resembles 1999 but with Greater Punishment for Stocks

Fool

Intuitive Surgical Faces Challenges and Opportunities

Fool

Long-Term Investment Opportunities Amid Market Uncertainty

NASDAQ.COM

05-10NASDAQ.COM

Long-Term Investment Potential of UPS, Hormel, and Medtronic

Fool

Medtronic Shares Decline, Investors Should Take Note

20 Analyst Rating

Wall Street analysts forecast MDT stock price to rise

11 Buy

9 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

102.00

Averages

111.76

High

120.00

Current: 0.000

Low

102.00

Averages

111.76

High

120.00

Jefferies

Matthew Taylor

Hold

downgrade

$108 -> $95

AI Analysis

2026-04-23

Reason

Jefferies

Matthew Taylor

Price Target

$108 -> $95

AI Analysis

2026-04-23

downgrade

Hold

Reason

Jefferies analyst Matthew Taylor lowered the firm's price target on Medtronic (MDT) to $95 from $108 and keeps a Hold rating on the shares. The firm updated its FY26 EPS outlook to reflect MiniMed (MMED) IPO timing and one-time expenses for Minimed Flex. Jefferies added that Medtronic's announced one-time $157M charge in Q4 related to the present value of future payments owed to Blackstone for the MiniMed Flex launch added to the EPS guide revision.

UBS

Neutral

downgrade

$104 -> $90

2026-04-22

Reason

UBS

Price Target

$104 -> $90

2026-04-22

downgrade

Neutral

Reason

UBS lowered the firm's price target on Medtronic to $90 from $104 and keeps a Neutral rating on the shares. The firm updated its model to reflect the diabetes separation.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for MDT

Unlock Now

Valuation Metrics

The current forward P/E ratio for Medtronic PLC (MDT.N) is 12.76, compared to its 5-year average forward P/E of 16.78. For a more detailed relative valuation and DCF analysis to assess Medtronic PLC's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

5Y Average PE

16.78

Current PE

12.76

Overvalued PE

19.10

Undervalued PE

14.47

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

5Y Average EV/EBITDA

14.27

Current EV/EBITDA

11.74

Overvalued EV/EBITDA

16.05

Undervalued EV/EBITDA

12.50

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

5Y Average PS

3.65

Current PS

2.62

Overvalued PS

4.32

Undervalued PS

2.99

Financials

AI Analysis

Annual

Quarterly

Whales Holding MDT

Schroder Investment Management Limited

HANSAINVEST Hanseatische Investment-GmbH

Citadel Advisors LLC

MAPFRE Asset Management

Dakota Wealth, LLC

Argenta Asset Management SA

Trading Trends

People Also Watch

Frequently Asked Questions

What is Medtronic PLC (MDT) stock price today?

The current price of MDT is 74.54 USD — it has decreased -2.11

What is Medtronic PLC (MDT)'s business?

Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.

What is the price predicton of MDT Stock?

Wall Street analysts forecast MDT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MDT is111.76 USD with a low forecast of 102.00 USD and a high forecast of 120.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Medtronic PLC (MDT)'s revenue for the last quarter?

Medtronic PLC revenue for the last quarter amounts to 9.02B USD, increased 8.74

What is Medtronic PLC (MDT)'s earnings per share (EPS) for the last quarter?

Medtronic PLC. EPS for the last quarter amounts to 0.89 USD, decreased -11.88

How many employees does Medtronic PLC (MDT). have?

Medtronic PLC (MDT) has 95000 emplpoyees as of May 12 2026.

What is Medtronic PLC (MDT) market cap?

Today MDT has the market capitalization of 95.70B USD.